Canada – Health Canada authorizes Pfizer’s mRNA vaccine under interim order

Health Canada has authorized the use of the COVID-19 vaccine co-developed by Pfizer and the German firm BioNTech for use in individuals 16 years of age and up. The authorization was made under the country’s interim order regarding drug importation, sale and advertising during the COVID-19 pandemic.
 
The first vaccine doses may be administered within days of the 9 December authorization, depending on transit and delivery logistics required to ship the first doses from Belgium to the 14 Canadian health centers that will first receive the messenger RNA (mRNA) vaccine, said Maj-Gen Dany Fortin, speaking at a 9 December press conference…